Home » All » Stock Forecast » Celldex Therapeutics Inc. Forecast

Celldex Therapeutics Inc. Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -0.38%Market Cap $2.28B · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$34.01 ▼ -0.71%	Yesterday	$34.35 ▲ +0.30%	Tomorrow's Celldex Therapeutics Inc. (CLDX) setup is anchored to $34.25 and targets $34.01 (-0.71%). The near-term read is downside; watch $35.28 / $33.22 because daily realized volatility is about 3.65%.
Tomorrow's Celldex Therapeutics Inc. (CLDX) setup is anchored to $34.25 and targets $34.01 (-0.71%). The near-term read is downside; watch $35.28 / $33.22 because daily realized volatility is about 3.65%.
Week	$33.50 ▼ -2.20%	Last Week	$34.57 ▲ +0.92%	The 7-day Celldex Therapeutics Inc. model moves from $34.57 to $33.50 (-2.20%). It gives downside momentum context for this stock, so breaks around $35.28 / $33.22 matter more than a single tick.
The 7-day Celldex Therapeutics Inc. model moves from $34.57 to $33.50 (-2.20%). It gives downside momentum context for this stock, so breaks around $35.28 / $33.22 matter more than a single tick.
Month	$32.65 ▼ -4.69%	Last Month	$34.92 ▲ +1.97%	The 1-month Celldex Therapeutics Inc. target is $32.65 (-4.69%), compared with the live reference near $34.25. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Celldex Therapeutics Inc. target is $32.65 (-4.69%), compared with the live reference near $34.25. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$31.37 ▼ -8.41%	Last Year	$35.46 ▲ +3.53%	The 1-year Celldex Therapeutics Inc. scenario points to $31.37 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Celldex Therapeutics Inc. scenario points to $31.37 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$28.38 ▼ -17.14%	5 Years Ago	$36.72 ▲ +7.20%	The 5-year Celldex Therapeutics Inc. view is $28.38 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Celldex Therapeutics Inc. view is $28.38 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$34.01▼ -0.71%

Yesterday$34.35▲ +0.30%

Tomorrow's Celldex Therapeutics Inc. (CLDX) setup is anchored to $34.25 and targets $34.01 (-0.71%). The near-term read is downside; watch $35.28 / $33.22 because daily realized volatility is about 3.65%.

Week$33.50▼ -2.20%

Last Week$34.57▲ +0.92%

The 7-day Celldex Therapeutics Inc. model moves from $34.57 to $33.50 (-2.20%). It gives downside momentum context for this stock, so breaks around $35.28 / $33.22 matter more than a single tick.

Month$32.65▼ -4.69%

Last Month$34.92▲ +1.97%

The 1-month Celldex Therapeutics Inc. target is $32.65 (-4.69%), compared with the live reference near $34.25. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$31.37▼ -8.41%

Last Year$35.46▲ +3.53%

The 1-year Celldex Therapeutics Inc. scenario points to $31.37 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$28.38▼ -17.14%

5 Years Ago$36.72▲ +7.20%

The 5-year Celldex Therapeutics Inc. view is $28.38 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bearish

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$34.25	Mid
Daily Change	-0.38%	Below
Volatility Cap	20.0%	Mid
Confidence	58%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$34.25

Daily Change-0.38%

Market Cap$2.28B

Sourcenasdaq-screener

Current	$34.25	Daily Change	-0.38%
Market Cap	$2.28B	Source	nasdaq-screener

Support & Resistance Levels

$33.22Support 1

$34.25Current

$35.28Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$34.25Live reference price

Used as the anchor for generated forecast calculations.

Next Month$32.65Model projection-4.69%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

58%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

58%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in CLDX today

Bullish Scenario

$35.96

+5.00% from current

Target Price$35.96

ScenarioUpside momentum

Probability50%

Base Scenario

$32.65

-4.69%

Target Price$32.65

ScenarioCapped drift

Probability58%

Bearish Scenario

$32.54

-5.00% from current

Target Price$32.54

ScenarioVolatility drawdown

Probability42%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 40/100

24H drift-0.71%

7D drift-2.20%

30D drift-4.69%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 35/100

1M outlook-4.69%

1Y outlook-8.41%

5Y outlook-17.14%

Frequently Asked Questions

Q What is the Celldex Therapeutics Inc. (CLDX) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Celldex Therapeutics Inc. is projected near $34.01 versus the current reference around $34.25. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for CLDX?

The weekly Celldex Therapeutics Inc. model points to $33.50, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Celldex Therapeutics Inc. 1-month and 1-year targets?

The Celldex Therapeutics Inc. 1-month target is $32.65 (-4.69%), while the 1-year target is $31.37 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Celldex Therapeutics Inc. 5-year scenario differ from short-term rows?

The Celldex Therapeutics Inc. long-horizon scenario sits near $28.38 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are CLDX support and resistance zones right now?

For Celldex Therapeutics Inc., nearest resistance is around $33.22, while nearest support is around $35.28. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Celldex Therapeutics Inc. market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.